Literature DB >> 17401112

The role of GW/P-bodies in RNA processing and silencing.

Andrew Jakymiw1, Kaleb M Pauley, Songqing Li, Keigo Ikeda, Shangli Lian, Theophany Eystathioy, Minoru Satoh, Marvin J Fritzler, Edward K L Chan.   

Abstract

GW bodies, also known as mammalian P-bodies, are cytoplasmic foci involved in the post-transcriptional regulation of eukaryotic gene expression. Recently, GW bodies have been linked to RNA interference and demonstrated to be important for short-interfering-RNA- and microRNA-mediated mRNA decay and translational repression. Evidence indicates that both passenger and guide strands of short-interfering RNA duplexes can localize to GW bodies, thereby indicating that RNA-induced silencing complexes may be activated within these cytoplasmic centers. Formation of GW bodies appears to depend on both specific protein factors and RNA, in particular, microRNA. Work over the past few years has significantly increased our understanding of the biology of GW bodies, revealing that they are specialized cell components that spatially regulate mRNA turnover in various biological processes. The formation of GW bodies appears to depend on both specific protein factors and RNA, in particular, microRNA. Here, we propose a working model for GW body assembly in terms of its relationship to RNA interference. In this process, one or more heteromeric protein complexes accumulate in successive steps into larger ribonucleoprotein structures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401112     DOI: 10.1242/jcs.03429

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  51 in total

1.  miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.

Authors:  Marc R Fabian; Maja K Cieplak; Filipp Frank; Masahiro Morita; Jonathan Green; Tharan Srikumar; Bhushan Nagar; Tadashi Yamamoto; Brian Raught; Thomas F Duchaine; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2011-10-07       Impact factor: 15.369

Review 2.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.

Authors:  Andrew Jakymiw; Rushi S Patel; Natasha Deming; Indraneel Bhattacharyya; Priya Shah; Richard J Lamont; Carol M Stewart; Donald M Cohen; Edward K L Chan
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

4.  LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing.

Authors:  Victoria James; Yining Zhang; Daniel E Foxler; Cornelia H de Moor; Yi Wen Kong; Thomas M Webb; Tim J Self; Yungfeng Feng; Dimitrios Lagos; Chia-Ying Chu; Tariq M Rana; Simon J Morley; Gregory D Longmore; Martin Bushell; Tyson V Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

5.  MicroRNA and their target mRNAs change expression in whole blood of patients after intracerebral hemorrhage.

Authors:  Xiyuan Cheng; Bradley P Ander; Glen C Jickling; Xinhua Zhan; Heather Hull; Frank R Sharp; Boryana Stamova
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-09       Impact factor: 6.200

Review 6.  Noncoding RNAs in the brain.

Authors:  John S Satterlee; Scott Barbee; Peng Jin; Anna Krichevsky; Sofie Salama; Gerhard Schratt; Da-Yu Wu
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 7.  siRNA and miRNA processing: new functions for Cajal bodies.

Authors:  Olga Pontes; Craig S Pikaard
Journal:  Curr Opin Genet Dev       Date:  2008-03-11       Impact factor: 5.578

8.  Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies.

Authors:  Ken Fujimura; Fumi Kano; Masayuki Murata
Journal:  RNA       Date:  2008-01-03       Impact factor: 4.942

9.  Clinical and serological features of patients with autoantibodies to GW/P bodies.

Authors:  Rahima A Bhanji; Theophany Eystathioy; Edward K L Chan; Donald B Bloch; Marvin J Fritzler
Journal:  Clin Immunol       Date:  2007-09-17       Impact factor: 3.969

Review 10.  MicroRNAs and autoimmunity.

Authors:  Angela Ceribelli; Minoru Satoh; Edward K L Chan
Journal:  Curr Opin Immunol       Date:  2012-08-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.